Gyon Technologies Capital Management’s AbbVie ABBV Stock Holding History

Gyon Technologies Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,893	Closed	-$469K	–	453
2022 Q1	$469K	Sell	2,893 -35,559	-92%	-$5.17M	0.33%	104
2021 Q4	$5.21M	Buy	38,452 +21,501	+127%	+$2.54M	0.96%	8
2021 Q3	$1.83M	Buy	+16,951	New	+$1.94M	0.49%	69
2021 Q2	–	Sell	-2,916	Closed	-$316K	–	344
2021 Q1	$316K	Sell	2,916 -812	-22%	-$86.9K	0.14%	260
2020 Q4	$399K	Sell	3,728 -1,701	-31%	-$163K	0.14%	206
2020 Q3	$476K	Buy	+5,429	New	+$511K	0.37%	102
2020 Q2	–	Sell	-6,278	Closed	-$478K	–	76
2020 Q1	$478K	Buy	+6,278	New	+$535K	0.92%	43

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gyon Technologies Capital Management's ABBV Position: Q2 2022 in Review

Gyon Technologies Capital Management sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 2,893 shares — an estimated $469K sold.

Gyon Technologies Capital Management first reported a position in ABBV in Q1 2020 and held it in 7 quarters. The position peaked at $5.21M in Q4 2021. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

Gyon Technologies Capital Management reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
Gyon Technologies Capital Management sold 2,893 AbbVie shares in Q2 2022, an estimated $469K.
Gyon Technologies Capital Management first reported a position in AbbVie in Q1 2020 and held it in 7 quarters.
Gyon Technologies Capital Management's AbbVie position peaked at $5.21M in Q4 2021.
3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.